Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.820
-0.010 (-0.55%)
At close: Mar 13, 2026, 4:00 PM EDT
1.810
-0.010 (-0.55%)
After-hours: Mar 13, 2026, 4:10 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $102.12 million as of March 13, 2026. Its market cap has decreased by -21.49% in one year.
Market Cap
102.12M
Enterprise Value
-60.12M
1-Year Change
-21.49%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $102.12M, a decrease of -96.88%. That is a compound annual growth rate of -48.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 102.12M | -0.80% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 106.30M |
| Oncolytics Biotech | 105.88M |
| Agenus | 105.43M |
| Verrica Pharmaceuticals | 104.96M |
| Gossamer Bio | 101.17M |
| Q32 Bio | 99.77M |
| Genelux | 98.93M |
| TuHURA Biosciences | 97.39M |